A shadow market for unlicensed slimming medications is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.
Experimental Treatment Gaining Traction Via Social Media
The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Followers are urged to contact these accounts directly for source information, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with numerous of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors market the drug there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Medical Experts Express Worries
Nevertheless, doctors and chemists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.
Some experts said the demand for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.
Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and customer regulations, potentially leading to fines, prosecution or imprisonment.
Platform Response and Material Elimination
According to the social media company, the service has taken down problematic content and prohibited associated keywords and query recommendations. The company said it was dedicated to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Research also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with numerous of members, filled with images of slimming results, glowing reviews and step-by-step instructions for preparing or injecting at residence.
Within minutes of joining one community, a vendor posted WhatsApp details, where the majority of transactions occur. The seller provided an guidebook and promised shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.
Item Information and Costs
Inside these communities, messages show black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how long a pen should last, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Security Actions
A representative for the messaging service stated it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are injecting substances they can’t verify. Although the research behind this drug is valid, these online versions may not include what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.
Her team has already encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental substance not yet approved … may subject users to potentially serious medical dangers”.
